Syngene International has announced the acquisition of its first biologics manufacturing site in the United States for $36.5 million, marking a significant expansion of its global presence in the ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and ...

As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...

Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter ...

The Baltimore Biologics Drug Substance facility will serve customers across human and animal health market segments.

Mathematics undergraduate Caleb Chalmer’s submission was awarded top honors, with reviewers noting “a ghostly quality to it ...

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading ...

Lessons learned from COVID-19 prepared the U.S. for the next viral scourge, but much of that progress is at risk of being unraveled, experts say.

Former Palm Beach Town Council President Margaret Zeidman led the town's response during the COVID-19 pandemic.